eISSN: 1643-3750

Logo




Get your full text copy in PDF

Cyclophosphamide pulses - intravenous treatment in patients with primary glomerulonephritis

Zofia Billip-Boniecka, Ryszard Gellert, Elżbieta Goliat, Wojciech Marusza, Kazimierz Ostrowski

Med Sci Monit 1997; 3(2): CR190-193

ID: 500690


The aim of the study was an evaluation of cyclophosphamide pulses treatment in 6 nephrotic syndrome patients with primary glomerulonephritis without renal failure but with contraindications to a steroid therapy. The medicine was given once a month, in 12 intravenous doses, 1000 mg each. After 6 month of this treatment an oedema disappeared and daily proteinuria decreased (from 13.8+-10.2g to 4.8+-4.4g) in all patients.The only observed side effects were as follows: nausea in 1 person and minimal transient increase of serum aminotransferases in all patients. In one year follow up (in 4 still observed patients) after this treatment, daily proteinuria was less than 1.0 g and kidneys were still sufficient. Conclusion: We propose such therapy as effective, safe and well tolerated.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree